Identifying and Validating Extracellular Matrix-Related Gene CTSH in Diabetic Foot Ulcer Using Bioinformatics and Machine Learning
Pei-Yu Wu,Yan-Lin Yu,Wen-Rui Zhao,Bo Zhou
DOI: https://doi.org/10.2147/jir.s467507
IF: 4.5
2024-09-02
Journal of Inflammation Research
Abstract:Pei-Yu Wu, 1, 2 Yan-Lin Yu, 1 Wen-Rui Zhao, 1 Bo Zhou 1 1 Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China; 2 Department of VIP, Chongqing General Hospital, Chongqing University, Chongqing, People's Republic of China Correspondence: Bo Zhou, Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Friendship Road, Yuzhong District, Chongqing, 400042, People's Republic of China, Email Background: Diabetic foot ulcer (DFU) is a serious clinical problem with high amputation and mortality rates, yet there is a lack of desirable therapy. While the extracellular matrix (ECM) contributes significantly to wound healing, ECM-related biomarker for DFU is still unknown. The study was designed to identify ECM-related biomarker in DFU using bioinformatics and machine learning and validate it in STZ-induced mice models. Methods: GSE80178 and GSE134431 microarray datasets were fetched from the GEO database, and differentially expressed genes (DEGs) analysis was performed, respectively. By analyzing DEGs and ECM genes, we identified ECM-related DEGs, and functional enrichment analysis was conducted. Subsequently, three machine learning algorithms (LASSO, RF and SVM-RFE) were applied to filter ECM-related DEGs to identify key ECM-related biomarkers. Next, we conducted immune infiltration analysis, GSEA, and correlation analysis to explore the hub gene underlying mechanism. A lncRNA-miRNA-mRNA and drug regulatory network were constructed. Finally, we validated the key ECM-related biomarker in STZ-induced mice models. Results: One hundred and forty-five common DEGs in adult DFU between the two datasets were identified. Taking the intersection of 145 common DEGs and 964 ECM genes, we identified 13 ECM-related DEGs. Thirteen ECM-related DEGs were mainly enriched in pathways associated with tissue remodeling, inflammation and defense against infectious agents. Ultimately, CTSH was identified as the key ECM-related biomarker. CTSH was associated with difference immune cells during the occurrence and development of DFU, and it influenced hedgehog, IL-17 and TNF signaling pathway. Additionally, CTSH expression is correlated with many ECM- and immune-related genes. A lncRNA-miRNA-mRNA and drug regulatory network were constructed with 10 lncRNAs, 2 miRNAs, CTSH and 1 drug. Finally, CTSH was validated as a key biomarker for DFU in animal models. Conclusion: Our study found that CTSH can be used for both diagnostic and prognostic purposes and might be a potential therapeutic target. Keywords: diabetic wound healing, extracellular matrix, bioinformatics, machine learning, CTSH Graphical Diabetic foot ulcer (DFU) is defined as a break of the foot skin in diabetic patients that affects at least the epidermis and part of dermis and is commonly accompanied by peripheral neuropathy and/or peripheral artery disease in the lower extremity. 1 DFU, a severe complication of diabetes, is linked to higher rates of amputation and mortality. DFUs are a significant health concern, currently affecting 6.3% of the global population with diabetes, with annual recurrence rates of 40%, and a 5-year mortality rate of 49.1%. 2,3 The standard care/conventional treatment for patients with DFU includes good glycemic control, wound debridement, offloading, infection control and the use of medical dressing. Furthermore, several other approaches like intralesional epidermal growth factor therapy 4 platelet-rich gel, 5 negative pressure wound therapy, 6 exosome 7 and stem cell therapy 8 also provide a viable alternative in the management of DFU. However, current treatments cannot achieve satisfactory results. DFU has become an urgent problem to be solved. Thus, it is essential to investigate the molecular changes and mechanism of DFU to improve the efficiency of DFU treatment. Wound healing is a dynamic and complex process that includes four overlapping stages: hemostasis or coagulation, inflammation, proliferation, and remodeling. The coordinated action of the extracellular matrix (ECM), numerous cell types and soluble mediators drive this process. 9 Given the importance of ECM in the process, investigating the ECM-related genes and mechanisms that are involved in diabetic wound healing is essential to find potential therapeutic targets. ECM is a complicated three-dimensional network structure, which not only provides essential physical scaffolding for cells but also provides a proper environment to induce cell adhesion, growth, migration, and differentiation. 10 In the process of w -Abstract Truncated-
immunology